Single Ascending Dose Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of HSD-016 Administered Orally to Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 17 Jul 2009
At a glance
- Drugs HSD 016 (Primary)
- Indications Diabetes mellitus
- Focus Adverse reactions
- 17 Jul 2009 End date (Feb 2009) added as reported by ClinicalTrials.gov.
- 17 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 13 Sep 2008 New trial record.